Literature DB >> 9512932

Comutagenesis--V: rapid conversion of 2-hydroxyl-amino-3-methylpyridineto 2-amino-3-methylpyridine by a hepatic S9 preparation.

J W Gorrod1, T G Altuntas.   

Abstract

The in vitro metabolism of 2-hydroxylamino-3-methylpyridine has been investigated using arochlor 1254 pretreated rat S9 mixtures. 2-Hydroxylamino-3-methylpyridine is rapidly converted to the parent amine 2-amino-3-methylpyridine. No further oxidation products of 2-hydroxylamino-3-methylpyridine (i.e. nitroso or nitro) were detected under the HPLC conditions used. This observation may explain our previous findings on the in vitro metabolism of 2-amino-3-methylpyridine where no hydroxylamino metabolite was detected.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9512932     DOI: 10.1007/BF03190968

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  Comutagenesis-II. Some factors influencing the in vitro metabolism of 2-amino-3-methylpyridine.

Authors:  T G Altuntas; J W Gorrod
Journal:  Drug Metabol Drug Interact       Date:  1997

2.  Biological N-oxidation of adenine and 9-alkyl derivatives.

Authors:  S P Lam; F Devinsky; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Oct-Dec       Impact factor: 2.441

Review 3.  The metabolic activation of carcinogenic aromatic amines and amides.

Authors:  J A Miller; E C Miller
Journal:  Prog Exp Tumor Res       Date:  1969

Review 4.  The biochemical production of ferrihemoglobin-forming derivatives from aromatic amines, and mechanisms of ferrihemoglobin formation.

Authors:  M Kiese
Journal:  Pharmacol Rev       Date:  1966-09       Impact factor: 25.468

Review 5.  Reductive drug metabolism.

Authors:  K E Mc Lane; J Fisher; K Ramakrishnan
Journal:  Drug Metab Rev       Date:  1983       Impact factor: 4.518

6.  Metabolic aspects of the comutagenic action of norharman.

Authors:  T Sugimura; M Nagao; K Wakabayashi
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

7.  Comutagenesis-III. In vitro metabolism of 2-amino-3-methylpyridine: the effect of various potential inhibitors, activators and inducers.

Authors:  T G Altuntas; J W Gorrod
Journal:  Xenobiotica       Date:  1997-11       Impact factor: 1.908

8.  Comutagenesis-IV in vitro metabolism of the comutagen 2-amino-3-methylpyridine: species differences and metabolic interaction with norharman.

Authors:  T G Altuntas; J W Gorrod
Journal:  Anticancer Res       Date:  1997 Nov-Dec       Impact factor: 2.480

9.  Metabolic N-oxygenation of 2,4-diamino-6-substituted pyrimidines.

Authors:  K el-Ghomari; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Oct-Dec       Impact factor: 2.441

10.  The reduction of 6-N-hydroxylaminopurine to adenine by xanthine oxidase.

Authors:  B Clement; T Kunze
Journal:  Biochem Pharmacol       Date:  1992-10-20       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.